Exogenous endoscopy-related infections, pseudo-infections, and toxic reactions: clinical and economic burden

Authors: Seoane-Vazquez, Enrique1; Rodriguez-Monguio, Rosa2; Visaria, Jay3; Carlson, Angeline4

Source: Current Medical Research and Opinion, Volume 22, Number 10, October 2006 , pp. 2007-2021(15)

Publisher: Informa Healthcare

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Objectives: The objective of this study was to analyze the characteristics and costs of exogenous endoscopy-related infections, pseudo-infections, and toxic reactions in the US.

Methods: A systematic review of the scientific literature published between 1966 and 2005 was conducted in Medline. Data collection was based on a prospective protocol developed by the authors.

Results: The literature review included 70 outbreaks described in 64 scientific articles. Bronchoscopy accounted for half of all reported outbreaks. Inadequate decontamination practices were the leading cause of contamination; equipment malfunction became the second leading cause of contamination during the period 1990-2004. More than 91% of the infections identified could be prevented by health care providers if quality control systems are improved and implemented. The available economic information concerning exogenous endoscope related events is very limited. A model for the analysis of the economic burden of exogenous endoscopy-related events is proposed.

Conclusions: Proper decontamination practices, the use of protective sheaths, and the improvement of surveillance systems could reduce the clinical and economic burdens associated with exogenous endoscopy-related events.

Keywords: COST ANALYSIS; ENDOSCOPY; HAZARDOUS CHEMICALS; MEDICAL DEVICES; NOSOCOMIAL INFECTIONS

Document Type: Review article

DOI: 10.1185/030079906X121048

Affiliations: 1: College of Pharmacy, The Ohio State University, Columbus, Ohio, USA; School of Public Health, The Ohio State University, Columbus, Ohio, USA; Center for Health Outcomes, Policy and Evaluation Studies, The Ohio State University, Columbus, Ohio, US 2: School of Public Health, The Ohio State University, Columbus, Ohio, USA; Center for Health Outcomes, Policy and Evaluation Studies, The Ohio State University, Columbus, Ohio, USA 3: College of Pharmacy, The Ohio State University, Columbus, Ohio, USA 4: Data Intelligence Consultants, LLC, and College of Pharmacy, University of Minnesota, Minneapolis, USA

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$51.50 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A